First-quarter sales for Orthofix International NV (NSDQ:OFIX) rocketed 507.6 percent on the strength of the sale of its vascular unit to Covidien plc (NYSE:COV) last month, as the Dutch firm posted a sales increase of 7.6 percent.
Orthofix, which maintains its U.S. headquarters in Boston, posted net income of $17.5 million, or 99 cents per share, on sales of $138.8 million. That compares with net income of $2.9 million, or 17 cents per share, during Q1 2009.